Graftide m500 mg
In stock
Description
Graftide-M 500 mg Tablet contains Mycophenolate Mofetil 500 mg, an immunosuppressant marketed by Mylan Pharmaceuticals Pvt. Ltd. (Viatris). It is mainly used to prevent rejection of transplanted organs, including kidney, heart, and liver transplants.
Key Information
Composition: Mycophenolate Mofetil 500 mg
Drug class: Immunosuppressant
Main use: Prevention of organ transplant rejection
Manufacturer/Marketer: Mylan Pharmaceuticals Pvt. Ltd. / Viatris
Dosage form: Oral tablet
Common pack: 10 tablets per strip
How it works:
Mycophenolate mofetil suppresses certain immune cells, reducing the immune system's ability to attack and reject a transplanted organ. It is commonly prescribed along with other immunosuppressive medicines.
